MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    CANVAS: think to assess cognition!

    K. Dujardin, C. Tard, E. Diglé, V. Herlin, E. Mutez, JB. Davion, A. Wissocq, V. Delforge, G. Kuchcinski, V. Huin (Lille, France)

    Objective: To determine the frequency and severity of cognitive impairment in RFC1-positive patients and comprehensively describe the pattern of cognitive disorders. Background: Cerebellar ataxia, neuropathy,…
  • 2024 International Congress

    Spatial Memory and Processing Speed as Cornerstones in Predicting Falls in Parkinson’s Disease

    S. Anis, E. Zimmerman, E. Jansen, R. Kaya, H. Fernandez, C. Lopez-Lennon, L. Dibble, A. Rosenfeldt, J. Alberts (Cleveland, USA)

    Objective: To build a fall prediction model that includes cognitive and motor outcomes in a subset of patients with Parkinson's disease (PwPD) enrolled in the…
  • 2024 International Congress

    Incident & Prevalent Dementia in Individuals with Parkinson’s Disease in the Framingham Heart Study

    J. Dookhy, Y. Li, A. Gurnani, S. O'Shea, S. Frank, R. Au, J. Mez, Y. Liu, TFA. Ang, L. Shih (Galway, Ireland)

    Objective: To examine incident and prevalent dementia cases in individuals with Parkinson's Disease (PD) within a longitudinal population-based study Background: Longitudinal studies have found that…
  • 2024 International Congress

    Critically Evaluating Best Practice Guidelines for Cognitive Impairment in Parkinson’s Disease: A Systematic Review (PDCogniCare)

    D. Pourzinal, D. Bailey, J. Yang, L. Mitchell, N. Pachana, D. Brooks, SA. Keramat, K. Shrubsole, J. Liddle, H. Tinson, S. Naismith, A. Lehn, R. Marsh, N. Dissanayaka (HERSTON, Australia)

    Objective: This systematic review aimed to critically evaluate current recommendations for evaluation, diagnosis and post-diagnostic care of cognitive impairment in Parkinson's disease (PD). Background: Methods…
  • 2024 International Congress

    The assessment of anxiety and depression comorbidities and the DRN electrophysiology in a primate model of Parkinson’s Disease

    A. Sadoun, M. Deffains, Q. Li, E. Bezard, F. Georges, E. Pioli (Floirac, France)

    Objective: The study aimed to examine the anxiety/depression-like phenotype and the potential role of dorsal raphe nucleus (DRN) in the gold standard primate model of…
  • 2024 International Congress

    Comparative Effectiveness of Behavioral or Drug Therapy for Overactive Bladder Symptoms in Parkinson Disease

    C. Vaughan, J. Morley, J. Lehosit, G. Mcgwin, L. Muirhead, A. Khakharia, T. Johnson Ii, M. Evatt, T. Sergent, K. Burgio, A. Markland (Atlanta, USA)

    Objective: Assess the comparative effectiveness of behavioral or solifenacin drug therapy over 12 weeks for overactive bladder (OAB) symptoms according to the International Consultation on…
  • 2024 International Congress

    Association Between Motor Symptoms and Autonomic Dysfunction in De Novo Parkinson’s Disease: Insights into the Role of the Gut-Brain Axis

    KY. Kwon, JE. Park (Seoul, Republic of Korea)

    Objective: This retrospective study aimed to investigate the relationship between motor symptoms and autonomic dysfunction in patients with de novo Parkinson's disease(PD). Background: Dysautonomia in…
  • 2024 International Congress

    Evaluating the Impact of the Pain Self-Management Program in PD

    A. Zawar (Lynnwood, USA)

    Objective: The program aims to provide PD individuals with skill sets, knowledge, and tools necessary to effectively self-manage their pain through non-pharmacological approaches. By empowering…
  • 2024 International Congress

    Unveiling Parkinson’s Disease Risk Factors in the European Population-Based HeBA Cohort

    A. Garrido, C. Horlings, K. Rege, S. Schade, S. Ghosh, P. Mahlknecht, R. Rawal, T. Marques, D. Pilco, C. Gomes, C. Pauly, F. Farfan, D. Mcintyre, K. Seppi, MJ. Marti, C. Trenkwalder, W. Poewe, E. Tolosa, V. Satagopam, R. Krüger, B. Mollenhauer (Barcelona, Spain)

    Objective: Describe the frequency of Parkinson’s disease (PD) risk factors in a European population-based study and analyze the predictive value of online survey single questions…
  • 2024 International Congress

    Clinical Predictors of Impulse Control Disorders in Parkinson’s Disease

    T. Breddy, P. Macdonald, K. van Hedger, H. Ganjavi (London, Canada)

    Objective: To investigate whether anxiety, depression, and sleep impairment relate to development of impulse control disorders (ICD) in patients with early-stage Parkinson’s disease (PD). Background:…
  • « Previous Page
  • 1
  • …
  • 25
  • 26
  • 27
  • 28
  • 29
  • …
  • 181
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley